Number of the records: 1  

skúšanie klinické, fáza IV, ako téma

  1. SYSd017327
    LBL
      
    00000cx--j2200000---45--
    005
      
    20240119201529.6
    100
      
    $a 19920513asloy0103----ba0
    152
      
    $b mesh
    250
      
    $a skúšanie klinické, fáza IV, ako téma $x CL $x EC $x ES $x HI $x IS $x LJ $x MT $x PX $x SN $x ST $x VE $8 slo
    300
    1-
    $a 2008(1993) $8 eng
    300
    1-
    $a Clinical Trials (1980-1992) $8 eng
    330
    1-
    $a Works about planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the U.S. and in other countries. $8 eng
    450
      
    $a pokusy klinické, štvrtá fáza, ako téma $5 e $8 slo
    450
      
    $a testy klinické, štvrtá fáza, ako téma $5 e $8 slo
    450
      
    $a štúdie klinické, fáza IV, ako téma $5 e $8 slo
    550
      
    $3 sllk_un_auth*d015337 $Y Multicenter Studies as Topic $5 B $a štúdie multicentrické ako téma
    550
      
    $3 sllk_un_auth*d064420 $Y Drug-Related Side Effects and Adverse Reactions $5 F $a účinky liekov vedľajšie a nežiaduce reakcie liekov
    550
      
    $3 sllk_un_auth*d064420 $Y Drug-Related Side Effects and Adverse Reactions $5 B $a účinky liekov vedľajšie a nežiaduce reakcie liekov
    675
      
    $a 615.036
    686
      
    $a E05.318.372.250.250.230
    686
      
    $a E05.337.800.200
    686
      
    $a N05.715.360.330.250.250.230
    686
      
    $a N06.850.520.450.250.250.230
    750
      
    $a Clinical Trials, Phase IV as Topic $8 eng
    801
    -0
    $a US $b DNLM $c 19920513
    801
    -2
    $a SK $b BA006 $c 19990922
    801
    -2
    $a SK $b BA006 $c 20080702
    801
    -2
    $a SK $b BA006 $c 20160216
    820
      
    $a for general design, methodology, economics, etc. of phase IV clinical trials; a different heading CLINICAL TRIAL, PHASE IV is used for reports of a specific phase IV clinical trial $8 eng
    980
      
    $x M
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.